Jonathan Pollack

@jonathanpollack.bsky.social

Photographer, jack of all trades | #IgANephropathy patient | Amateur researcher | #STL | www.iganclarity.com

Any experience with generic budesonide versus Tarpeyo(targeted release budesonide) for IgA nephropathy? All I can find are proteinuria studies and increased risk of systemic side effects. Blue Cross wants patient to fail generic budesonide for 3 months before approving Tarpeyo. #askrenal